SPOTLIGHT -
Washington, DC-The ophthalmic community is seeing the fruits of its labor with the U.S. House passage of the "Medicare Prescription Drug and Modernization Act of 2003." The act calls for Medicare physician updates of at least 1.5% in 2004 and 2005.
SalioGen Therapeutics taps development candidate for ABCA4-mediated Stargardt disease
(EyePod) From idea to impact: Navigating ophthalmic innovation
Ocular Therapeutix announces positive topline Phase 1 data for Axpaxli in diabetic retinopathy
EyePod: Modifier Gene Therapy: What is it?
Patients with dry eye suffer from worse sleep quality
Ophthalmic industry veteran Erin Schallhorn Powers joins Holland Foundation for Sight Restoration Board of Directors